Inflammation and Adipose Tissue in Uremia

Shinohara, 2002, Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease, J Am Soc Nephrol, 13, 1894, 10.1097/01.ASN.0000019900.87535.43 Zoccali, 2002, Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease, J Am Soc Nephrol, 13, 134, 10.1681/ASN.V131134 Yao, 2004, Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease, Scand J Urol Nephrol, 38, 405, 10.1080/00365590410031715 Stenvinkel, 2000, Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass, J Am Soc Nephrol, 11, 1303, 10.1681/ASN.V1171303 Kaysen, 2005, Effects of inflammation on plasma composition and endothelial structure and function, J Ren Nutr, 15, 94, 10.1053/j.jrn.2004.09.021 Rajala, 2003, Minireview, Endocrinology, 144, 3765, 10.1210/en.2003-0580 Kershaw, 2004, Adipose tissue as an endocrine organ, J Clin Endocrinol Metab, 89, 10.1210/jc.2004-0395 Friedman, 1998, Leptin and the regulation of body weight in mammals, Nature, 395, 763, 10.1038/27376 Barazzoni, 2004, Skeletal muscle mitochondrial protein metabolism and function in ageing and type 2 diabetes, Curr Opin Clin Nutr Metab Care, 7, 97, 10.1097/00075197-200401000-00015 Loffreda, 1998, Leptin regulates proinflammatory immune responses, FASEB J, 12, 57, 10.1096/fasebj.12.1.57 Ajuwon, 2005, Adiponectin inhibits LPS-induced NFκB activation and IL-6 production, and increases PPARγ2 expression in adipocytes, Am J Physiol Regul Integr Comp Physiol, 288, R1220, 10.1152/ajpregu.00397.2004 Yamauchi, 2002, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, Nat Med, 8, 1288, 10.1038/nm788 Vendrell, 2004, Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines, Obes Res, 12, 962, 10.1038/oby.2004.118 Wing, 1987, Long-term effects of modest weight loss in type II diabetic patients, Arch Intern Med, 147, 1749, 10.1001/archinte.147.10.1749 Guarnieri, 1983, Muscle biopsy studies in chronically uremic patients, Kidney Int Suppl, 16, S187 Kalanthar-Zadeh, 2004, Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure, Semin Dial, 17, 455, 10.1111/j.0894-0959.2004.17606.x Sohal, 1994, Effect of age and caloric restriction on DNA oxidative damage in different tissue of C57BL/6 mice, Mech Ageing Dev, 76, 215, 10.1016/0047-6374(94)91595-4 Witko-Sarsat, 1998, Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure, J Immunol, 161, 2524, 10.4049/jimmunol.161.5.2524 Furukawa, 2004, Increased oxidative stress in obesity and its impact on metabolic syndrome, J Clin Invest, 114, 1752, 10.1172/JCI21625 Evans, 2003, Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?, Diabetes, 52, 1, 10.2337/diabetes.52.1.1 Tschop, 2001, Circulating ghrelin levels are decreased in human obesity, Diabetes, 50, 707, 10.2337/diabetes.50.4.707 Barazzoni, 2003, Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats, Gastroenterology, 124, 1188, 10.1016/S0016-5085(03)00281-6 Barazzoni, 2005, Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle, Am J Physiol Endocrinol Metab, 288, E228, 10.1152/ajpendo.00115.2004 Poykko, 2003, Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes, Diabetes, 52, 2546, 10.2337/diabetes.52.10.2546 Dixit, 2004, Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells, J Clin Invest, 114, 57, 10.1172/JCI200421134 Saad, 2002, Insulin regulates plasma ghrelin concentration, J Clin Endocrinol Metab, 87, 3997, 10.1210/jc.87.8.3997 Saad, 1998, Physiological insulinemia acutely modulates plasma leptin, Diabetes, 47, 544, 10.2337/diabetes.47.4.544 Brame, 2005, Insulin and endothelin in the acute regulation of adiponectin in vivo in humans, Obes Res, 13, 582, 10.1038/oby.2005.62 Merabet, 1997, Increased plasma leptin concentration in end-stage renal disease, J Clin Endocrinol Metab, 82, 847, 10.1210/jc.82.3.847 Guarnieri, 2003, Mechanisms of malnutrition in uremia, J Ren Nutr, 12, 153, 10.1053/jren.2003.50020 Guebre-Egziabher, 2005, Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function, Nephrol Dial Transplant, 20, 129, 10.1093/ndt/gfh568 Yoshimoto, 2002, Plasma ghrelin and desacyl ghrelin concentrations in renal failure, J Am Soc Nephrol, 13, 2748, 10.1097/01.ASN.0000032420.12455.74 Nordfors, 1998, Low leptin gene expression and hyperleptinemia in chronic renal failure, Kidney Int, 54, 1267, 10.1046/j.1523-1755.1998.00088.x Stompor, 2003, An association between body mass index and markers of inflammation, Perit Dial Int, 23, 79, 10.1177/089686080302300112